<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38623399</PMID><DateRevised><Year>2024</Year><Month>04</Month><Day>25</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2589-5370</ISSN><JournalIssue CitedMedium="Internet"><Volume>71</Volume><PubDate><Year>2024</Year><Month>May</Month></PubDate></JournalIssue><Title>EClinicalMedicine</Title><ISOAbbreviation>EClinicalMedicine</ISOAbbreviation></Journal><ArticleTitle>Prevalence and risk factors for long COVID among adults in Scotland using electronic health records: a national, retrospective, observational cohort study.</ArticleTitle><Pagination><StartPage>102590</StartPage><MedlinePgn>102590</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">102590</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.eclinm.2024.102590</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Long COVID is a debilitating multisystem condition. The objective of this study was to estimate the prevalence of long COVID in the adult population of Scotland, and to identify risk factors associated with its development.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">In this national, retrospective, observational cohort study, we analysed electronic health records (EHRs) for all adults (&#x2265;18 years) registered with a general medical practice and resident in Scotland between March 1, 2020, and October 26, 2022 (98-99% of the population). We linked data from primary care, secondary care, laboratory testing and prescribing. Four outcome measures were used to identify long COVID: clinical codes, free text in primary care records, free text on sick notes, and a novel operational definition. The operational definition was developed using Poisson regression to identify clinical encounters indicative of long COVID from a sample of negative and positive COVID-19 cases matched on time-varying propensity to test positive for SARS-CoV-2. Possible risk factors for long COVID were identified by stratifying descriptive statistics by long COVID status.</AbstractText><AbstractText Label="FINDINGS" NlmCategory="UNASSIGNED">Of 4,676,390 participants, 81,219 (1.7%) were identified as having long COVID. Clinical codes identified the fewest cases (n&#xa0;=&#xa0;1,092, 0.02%), followed by free text (n&#xa0;=&#xa0;8,368, 0.2%), sick notes (n&#xa0;=&#xa0;14,469, 0.3%), and the operational definition (n&#xa0;=&#xa0;64,193, 1.4%). There was limited overlap in cases identified by the measures; however, temporal trends and patient characteristics were consistent across measures. Compared with the general population, a higher proportion of people with long COVID were female (65.1% versus 50.4%), aged 38-67 (63.7% versus 48.9%), overweight or obese (45.7% versus 29.4%), had one or more comorbidities (52.7% versus 36.0%), were immunosuppressed (6.9% versus 3.2%), shielding (7.9% versus 3.4%), or hospitalised within 28 days of testing positive (8.8% versus 3.3%%), and had tested positive before Omicron became the dominant variant (44.9% versus 35.9%). The operational definition identified long COVID cases with combinations of clinical encounters (from four symptoms, six investigation types, and seven management strategies) recorded in EHRs within 4-26 weeks of a positive SARS-CoV-2 test. These combinations were significantly (p&#xa0;&lt;&#xa0;0.0001) more prevalent in positive COVID-19 patients than in matched negative controls. In a case-crossover analysis, 16.4% of those identified by the operational definition had similar healthcare patterns recorded before testing positive.</AbstractText><AbstractText Label="INTERPRETATION" NlmCategory="UNASSIGNED">The prevalence of long COVID presenting in general practice was estimated to be 0.02-1.7%, depending on the measure used. Due to challenges in diagnosing long COVID and inconsistent recording of information in EHRs, the true prevalence of long COVID is likely to be higher. The operational definition provided a novel approach but relied on a restricted set of symptoms and may misclassify individuals with pre-existing health conditions. Further research is needed to refine and validate this approach.</AbstractText><AbstractText Label="FUNDING" NlmCategory="UNASSIGNED">Chief Scientist Office (Scotland), Medical Research Council, and BREATHE.</AbstractText><CopyrightInformation>&#xa9; 2024 Published by Elsevier Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Jeffrey</LastName><ForeName>Karen</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Usher Institute, University of Edinburgh, Edinburgh, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Woolford</LastName><ForeName>Lana</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Usher Institute, University of Edinburgh, Edinburgh, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maini</LastName><ForeName>Rishma</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Public Health Scotland, Glasgow and Edinburgh, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Basetti</LastName><ForeName>Siddharth</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>NHS Highland, Inverness, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Batchelor</LastName><ForeName>Ashleigh</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Patient and Public Contributors, Usher Institute, University of Edinburgh, Edinburgh, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weatherill</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Patient and Public Contributors, Usher Institute, University of Edinburgh, Edinburgh, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>White</LastName><ForeName>Chris</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Patient and Public Contributors, Usher Institute, University of Edinburgh, Edinburgh, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hammersley</LastName><ForeName>Vicky</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Usher Institute, University of Edinburgh, Edinburgh, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Millington</LastName><ForeName>Tristan</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Usher Institute, University of Edinburgh, Edinburgh, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Macdonald</LastName><ForeName>Calum</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Usher Institute, University of Edinburgh, Edinburgh, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Quint</LastName><ForeName>Jennifer K</ForeName><Initials>JK</Initials><AffiliationInfo><Affiliation>National Heart and Lung Institute, Imperial College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kerr</LastName><ForeName>Robin</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>NHS Borders, Melrose, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>NHS Dumfries &amp; Galloway, Dumfries, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kerr</LastName><ForeName>Steven</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Usher Institute, University of Edinburgh, Edinburgh, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shah</LastName><ForeName>Syed Ahmar</ForeName><Initials>SA</Initials><AffiliationInfo><Affiliation>Usher Institute, University of Edinburgh, Edinburgh, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rudan</LastName><ForeName>Igor</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Usher Institute, University of Edinburgh, Edinburgh, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fagbamigbe</LastName><ForeName>Adeniyi Francis</ForeName><Initials>AF</Initials><AffiliationInfo><Affiliation>Institute of Applied Health Sciences, University of Aberdeen, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Simpson</LastName><ForeName>Colin R</ForeName><Initials>CR</Initials><AffiliationInfo><Affiliation>Usher Institute, University of Edinburgh, Edinburgh, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Health, Wellington Faculty of Health, Victoria University of Wellington, Wellington, NZ.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Katikireddi</LastName><ForeName>Srinivasa Vittal</ForeName><Initials>SV</Initials><AffiliationInfo><Affiliation>Public Health Scotland, Glasgow and Edinburgh, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>MRC/CSO Social &amp; Public Health Sciences Unit, University of Glasgow, Glasgow, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Robertson</LastName><ForeName>Chris</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Public Health Scotland, Glasgow and Edinburgh, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Mathematics and Statistics, University of Strathclyde, Glasgow, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ritchie</LastName><ForeName>Lewis</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Academic Primary Care, University of Aberdeen, Aberdeen, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Applied Health Sciences, University of Aberdeen, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sheikh</LastName><ForeName>Aziz</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Usher Institute, University of Edinburgh, Edinburgh, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Daines</LastName><ForeName>Luke</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Usher Institute, University of Edinburgh, Edinburgh, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>04</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>EClinicalMedicine</MedlineTA><NlmUniqueID>101733727</NlmUniqueID><ISSNLinking>2589-5370</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Clinical coding</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Matched-pair analysis</Keyword><Keyword MajorTopicYN="N">Population surveillance</Keyword><Keyword MajorTopicYN="N">Primary health care</Keyword></KeywordList><CoiStatement>AS reports grants from HDRUK, NIHR, MRC, ICSF, and CSO during the conduct of the study; and being a Member of the Scottish Government's CMO COVID-19 Advisory Group and Standing Committee on Pandemics. CR reports support from PHS, CSO and MRC; and being a Member of SPI-M, Scottish Government Scientific Advisory Committee, MHRA Covid vaccine benefit and risk expert working group. CS reports grants from MBIE (New Zealand), Ministry of Health (New Zealand), and HRC (New Zealand). JKQ reports grants from MRC, HDR UK, GlaxoSmithKline, BI, Asthma&#xa0;+&#xa0;Lung UK, and AstraZeneca and consulting fees from GlaxoSmithKline, Evidera, AstraZeneca, Insmed. SVK reports grants from CSO and MRC. All other authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>11</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>3</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>3</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>4</Month><Day>16</Day><Hour>12</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>4</Month><Day>16</Day><Hour>12</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>4</Month><Day>16</Day><Hour>3</Hour><Minute>39</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>4</Month><Day>11</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38623399</ArticleId><ArticleId IdType="pmc">PMC11016856</ArticleId><ArticleId IdType="doi">10.1016/j.eclinm.2024.102590</ArticleId><ArticleId IdType="pii">S2589-5370(24)00169-X</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Davis H.E., McCorkell L., Vogel J.M., Topol E.J. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol. 2023;21:133&#x2013;146.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Soriano J.B., Murthy S., Marshall J.C., Relan P., Diaz J.V., Group W.C. A&#xa0;clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect Dis. 2022;22(4):e102&#x2013;e107.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Han Q., Zheng B., Daines L., Sheikh A. Long-Term sequelae of COVID-19: a systematic review and meta-analysis of one-year follow-up studies on post-COVID symptoms. Pathogens. 2022;11(2):269.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8875269</ArticleId><ArticleId IdType="pubmed">35215212</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y., Al-Aly Z. Risks and burdens of incident diabetes in long COVID: a cohort study. Lancet Diabetes Endocrinol. 2022;10(5):311&#x2013;321.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8937253</ArticleId><ArticleId IdType="pubmed">35325624</ArticleId></ArticleIdList></Reference><Reference><Citation>Knight R., Walker V., Ip S., et al. Association of COVID-19 with major arterial and venous thrombotic diseases: a population-wide cohort study of 48 million adults in England and Wales. Circulation. 2022;146(12):892&#x2013;906.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9484653</ArticleId><ArticleId IdType="pubmed">36121907</ArticleId></ArticleIdList></Reference><Reference><Citation>Larsen N.W., Stiles L.E., Miglis M.G. Preparing for the long-haul: autonomic complications of COVID-19. Auton Neurosci. 2021;235</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8254396</ArticleId><ArticleId IdType="pubmed">34265539</ArticleId></ArticleIdList></Reference><Reference><Citation>Office for National Statistics  Prevalence of ongoing symptoms&#xa0;following coronavirus (COVID-19) infection in the UK: 30 March 2023. https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/prevalenceofongoingsymptomsfollowingcoronaviruscovid19infectionintheuk/2february2023 Available from:</Citation></Reference><Reference><Citation>Birtwistle S., Deakin E., Whitford R., Hinchliffe S., Daniels-Creasey A., Rule S. The scottish health survey. 2021 edition. vol. 1. Main Report. Scottish Government; 2022.</Citation></Reference><Reference><Citation>Hastie C.E., Lowe D.J., McAuley A., et al. Outcomes among confirmed cases and a matched comparison group in the Long-COVID in Scotland study. Nat Commun. 2022;13(1):5663.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9556711</ArticleId><ArticleId IdType="pubmed">36224173</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitaker M., Elliott J., Chadeau-Hyam M., et al. Persistent COVID-19 symptoms in a community study of 606,434 people in England. Nat Commun. 2022;13(1):1957.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9005552</ArticleId><ArticleId IdType="pubmed">35413949</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson E.J., Williams D.M., Walker A.J., et al. Long COVID burden and risk factors in 10 UK longitudinal studies and electronic health records. Nat Commun. 2022;13(1):3528.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9240035</ArticleId><ArticleId IdType="pubmed">35764621</ArticleId></ArticleIdList></Reference><Reference><Citation>Walker A.J., MacKenna B., Inglesby P., et al. Clinical coding of long COVID in English primary care: a federated analysis of 58 million patient records in situ using OpenSAFELY. Br J Gen Pract. 2021;71(712):e806&#x2013;e814.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8340730</ArticleId><ArticleId IdType="pubmed">34340970</ArticleId></ArticleIdList></Reference><Reference><Citation>Pfaff E.R., Girvin A.T., Bennett T.D., et al. Identifying who has long COVID in the USA: a machine learning approach using N3C data. Lancet Digit Health. 2022;4(7):e532&#x2013;e541.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9110014</ArticleId><ArticleId IdType="pubmed">35589549</ArticleId></ArticleIdList></Reference><Reference><Citation>Kessler R., Philipp J., Wilfer J., Kostev K. Predictive attributes for developing long COVID&#x2014;a study using machine learning and real-world data from primary care physicians in Germany. J&#xa0;Clin Med. 2023;12(10):3511.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10219004</ArticleId><ArticleId IdType="pubmed">37240616</ArticleId></ArticleIdList></Reference><Reference><Citation>Kingstone T., Taylor A.K., O'Donnell C.A., et al. Finding the &#x2018;right&#x2019; GP: a qualitative study of the experiences of people with long-COVID. BJGP Open. 2020;4(5) doi: 10.3399/bjgpopen20X101143.</Citation><ArticleIdList><ArticleId IdType="doi">10.3399/bjgpopen20X101143</ArticleId><ArticleId IdType="pmc">PMC7880173</ArticleId><ArticleId IdType="pubmed">33051223</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M., Dercon Q., Luciano S., et al. Incidence, co-occurrence, and evolution of long-COVID features: a 6-month retrospective cohort study of 273,618 survivors of COVID-19. PLoS Med. 2021;18(9)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8478214</ArticleId><ArticleId IdType="pubmed">34582441</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y., Bowe B., Al-Aly Z. Burdens of post-acute sequelae of COVID-19 by severity of acute infection, demographics and health status. Nat Commun. 2021;12(1):6571.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8589966</ArticleId><ArticleId IdType="pubmed">34772922</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H., Zang C., Xu Z., et al. Data-driven identification of post-acute SARS-CoV-2 infection subphenotypes. Nat Med. 2023;29:226&#x2013;235. doi: 10.1038/s41591-022-02116-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-02116-3</ArticleId><ArticleId IdType="pmc">PMC9873564</ArticleId><ArticleId IdType="pubmed">36456834</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L., Foer D., MacPhaul E., et al. PASCLex: a comprehensive post-acute sequelae of COVID-19 (PASC) symptom lexicon derived from electronic health record clinical notes. J&#xa0;Biomed Inf. 2022;125</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8590503</ArticleId><ArticleId IdType="pubmed">34785382</ArticleId></ArticleIdList></Reference><Reference><Citation>Daines L., Mulholland R.H., Vasileiou E., et al. Deriving and validating a risk prediction model for long COVID-19: protocol for an observational cohort study using linked Scottish data. BMJ Open. 2022;12(7)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9260199</ArticleId><ArticleId IdType="pubmed">35793922</ArticleId></ArticleIdList></Reference><Reference><Citation>Von Elm E., Altman D.G., Egger M., et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Ann Intern Med. 2007;147(8):573&#x2013;577.</Citation><ArticleIdList><ArticleId IdType="pubmed">17938396</ArticleId></ArticleIdList></Reference><Reference><Citation>Mulholland R.H., Vasileiou E., Simpson C.R., et al. Cohort profile: early pandemic evaluation and enhanced surveillance of COVID-19 (EAVE II) database. Int J Epidemiol. 2021;50(4):1064&#x2013;1074.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8195245</ArticleId><ArticleId IdType="pubmed">34089614</ArticleId></ArticleIdList></Reference><Reference><Citation>Public Health Scotland  Grouping of codes for conditions (RCGs) https://www.isdscotland.org/Health-Topics/General-Practice/GP-Consultations/Grouping-clinical-codes.asp</Citation></Reference><Reference><Citation>Whittaker H.R., Gulea C., Koteci A., et al. GP consultation rates for sequelae after acute covid-19 in patients managed in the community or hospital in the UK: population based study. BMJ. 2021;375</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8715128</ArticleId><ArticleId IdType="pubmed">34965929</ArticleId></ArticleIdList></Reference><Reference><Citation>Scottish Government  . 2020. Management and recording of the long-term effects of COVID-19 (Long COVID)https://www.scimp.scot.nhs.uk/wp-content/uploads/CMO-Letter-09.03.21.pdf Available from:</Citation></Reference><Reference><Citation>National Institute for Health and Care Excellence  . 2020. COVID-19 rapid guideline: managing the long-term effects of COVID-19.https://www.nice.org.uk/guidance/ng188 Last updated: 11 November 2021. Available from:</Citation><ArticleIdList><ArticleId IdType="pubmed">33555768</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah A.D., Subramanian A., Lewis J., et al. Long Covid symptoms and diagnosis in primary care: a cohort study using structured and unstructured data in the Health Improvement Network primary care database. PLoS One. 2023;18(9) doi: 10.1371/journal.pone.0290583.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0290583</ArticleId><ArticleId IdType="pmc">PMC10521988</ArticleId><ArticleId IdType="pubmed">37751444</ArticleId></ArticleIdList></Reference><Reference><Citation>Benjamini Y., Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J&#xa0;Roy Stat Soc B. 1995;57(1):289&#x2013;300.</Citation></Reference><Reference><Citation>Magnusson K., Kristoffersen D.T., Dell'Isola A., et al. Post-covid medical complaints following infection with SARS-CoV-2 Omicron vs Delta variants. Nat Commun. 2022;13(1):1&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9709355</ArticleId><ArticleId IdType="pubmed">36450749</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>